These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 206056)

  • 1. [Inhibition of metabolism of triglyceride-rich lipoproteins by postheparin lipolytic activity in hyperlipoproteinemia type III].
    Augustin J; Geursen R; Wieland H; Klose G; Greten H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():387-9. PubMed ID: 206056
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.
    Brunzell JD; Hazzard WR; Porte D; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1578-85. PubMed ID: 4352459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acid metabolism in hyperlipoproteinaemia.
    Hellström K; Einarsson K
    Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipoprotein binding and hypertriglyceridemia in chronic uremia.
    Samar RE; Moncrief JW; Decherd JF; Popovich RP
    Trans Am Soc Artif Intern Organs; 1975; 21():455-63. PubMed ID: 167492
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relationship between the activity of lecithin cholesterol acyltransferase, hyperlipoproteinemia type and the indicators of the system of hemostasis in chronic ischemic heart disease].
    Furkalo NK; Bol'shakova RM; Solovtsova KM; Mkhitarian LS; Progonnaia VV
    Vrach Delo; 1978 Dec; (12):33-8. PubMed ID: 217177
    [No Abstract]   [Full Text] [Related]  

  • 7. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).
    Hazzard WR; Bierman EL
    Metabolism; 1976 Jul; 25(7):777-801. PubMed ID: 181657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia.
    Krauss RM; Levy RI; Fredrickson DS
    J Clin Invest; 1974 Nov; 54(5):1107-24. PubMed ID: 4370795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on serum lipoproteins of rats developing spontaneous hyperlipidemia.
    Gustafsson K; Kiessling H
    Artery; 1981; 9(6):456-76. PubMed ID: 7337554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein metabolism in patients with chronic uremia. Effect of hemodialysis on serum lipoproteins and postheparin plasma triglyceride lipases.
    Huttunen JK; Pasternack A; Vänttinen T; Ehnholm C; Nikkilä EA
    Acta Med Scand; 1978; 204(3):211-8. PubMed ID: 211802
    [No Abstract]   [Full Text] [Related]  

  • 11. Abnormal fat metabolism in chronic renal failure.
    Romics L; Makó J
    Acta Med Acad Sci Hung; 1978; 35(3-4):233-40. PubMed ID: 227218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperlipoproteinemia].
    Meinders AE
    Ned Tijdschr Geneeskd; 1979 Mar; 123(15):617-28. PubMed ID: 219378
    [No Abstract]   [Full Text] [Related]  

  • 13. Xanthomatosis and hyperlipoproteinemia; a review.
    Polano MK
    Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
    [No Abstract]   [Full Text] [Related]  

  • 14. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A
    Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract]   [Full Text] [Related]  

  • 15. [Apolipoprotein abnormalities in low and very low density lipoproteins in a type V hyperlipemia (author's transl)].
    Beucler I; Salmon S; Ayrault M; Raymond JP; Etienne J; Polonovski J
    Pathol Biol (Paris); 1977 Feb; 25(2):95-9. PubMed ID: 191781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The LDL VLDL heparin Ca++ complex and the detectability of hyperlipoproteinemia in mass examination].
    Makurat D
    Wiad Lek; 1977 Dec; 30(23):1797-800. PubMed ID: 203123
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical aspects of hyperlipoproteinemia.
    Crepaldi G; Fellin R
    Ann Biol Clin (Paris); 1974; 32(4):309-22. PubMed ID: 4376343
    [No Abstract]   [Full Text] [Related]  

  • 18. [Classification of hyperlipoproteinemia. II. Distribution principle of hyperlipoproteinemias according to Fredrickson et al. correlated with clinical dermatological possibilities].
    Zabel R
    Dermatol Monatsschr; 1973 Dec; 159(12):1137-43. PubMed ID: 4366868
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
    Weisweiler P; Schwandt P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():398-401. PubMed ID: 206058
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.